92
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

A Linear Prediction Rule Based on Ensemble Classifiers for Non-Genotoxic Carcinogenicity

, , &
Pages 185-193 | Received 01 May 2010, Published online: 10 Aug 2012
 

Abstract

This article presents a novel approach for developing a linear prediction rule to predict the non-genotoxic carcinogenicity potential of a new compound in the drug development pipeline. We construct the approach using data from 24-hour microarray experiments on rats treated with the compound. This method was developed to address an actual problem that we were presented with by scientists in mechanistic toxicology. Short-term, preclinical assays for non-genotoxic carcinogenicity, a toxicity commonly observed in long-term rodent carcinogenicity studies, have proven difficult to develop. A quick and early preclinical assay, such as this, is of particular interest and urgency. The linear prediction rule is derived using an Ensemble Linear Discriminant classifier. This is a hybrid approach which leverages the advantages of ensemble approaches for addressing over-fitting (a problem endemic to microarray data), and that of LDA for interpretability. In a limited comparison with some other classifiers, including random forest, we show that our approach has good predictive performance in addition to being interpretable.

Acknowledgments

The authors would like to thank James Colaianne and Peter Lord for their support of this work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.